Bio Gene Technology Stock Annual Yield
| BGT Stock | 0.04 0 2.33% |
Bio Gene Technology fundamentals help investors to digest information that contributes to Bio Gene's financial success or failures. It also enables traders to predict the movement of Bio Stock. The fundamental analysis module provides a way to measure Bio Gene's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bio Gene stock.
Bio | Annual Yield |
Bio Gene Technology Company Annual Yield Analysis
Bio Gene's Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
| Competition |
In accordance with the recently published financial statements, Bio Gene Technology has an Annual Yield of 0.0%. This indicator is about the same for the Chemicals average (which is currently at 0.0) sector and about the same as Materials (which currently averages 0.0) industry. This indicator is about the same for all Australia stocks average (which is currently at 0.0).
Bio Annual Yield Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bio Gene's direct or indirect competition against its Annual Yield to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bio Gene could also be used in its relative valuation, which is a method of valuing Bio Gene by comparing valuation metrics of similar companies.Bio Gene is currently under evaluation in annual yield category among its peers.
Bio Fundamentals
| Return On Equity | -0.8 | |||
| Return On Asset | -0.45 | |||
| Current Valuation | 6.45 M | |||
| Shares Outstanding | 201.36 M | |||
| Shares Owned By Insiders | 43.33 % | |||
| Price To Book | 3.10 X | |||
| Price To Sales | 483.62 X | |||
| Revenue | 18.32 K | |||
| Gross Profit | 222.1 K | |||
| EBITDA | (2.97 M) | |||
| Net Income | (2.41 M) | |||
| Total Debt | 368.45 K | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | (2.75 M) | |||
| Earnings Per Share | (0.01) X | |||
| Target Price | 0.37 | |||
| Beta | 0.71 | |||
| Market Capitalization | 8.86 M | |||
| Total Asset | 3.16 M | |||
| Retained Earnings | (19.64 M) | |||
| Working Capital | 2.59 M | |||
| Net Asset | 3.16 M |
About Bio Gene Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bio Gene Technology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bio Gene using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bio Gene Technology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Bio Stock Analysis
When running Bio Gene's price analysis, check to measure Bio Gene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Gene is operating at the current time. Most of Bio Gene's value examination focuses on studying past and present price action to predict the probability of Bio Gene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Gene's price. Additionally, you may evaluate how the addition of Bio Gene to your portfolios can decrease your overall portfolio volatility.